上海市医保局局长夏科家在3月1日表示，为进一步促进创新药械发展，上海市将出台《上海市进一步完善多元支付机制支持创新药械发展的若干措施》。这一政策的核心目标是建立多元支付保障机制，以激励医疗机构更积极地引进创新药械，让参保群众更放心地使用这些创新产品，同时也鼓励创新医药企业更勇敢地进行研发。
夏科家指出，新政策的推出旨在打破传统医保支付模式的限制，为创新药械提供更加灵活、多样化的支付方式。通过完善多元支付机制，上海市希望能够让医疗机构在选择使用创新药械时更加敢于冒进，为患者提供更好的治疗选择；同时，让参保群众在需要使用创新药械时更加有信心，不必过多担心费用问题；最重要的是，鼓励创新医药企业在研发过程中更具冒险精神，推动医药科技的不断进步。
这项政策的出台将为上海市的医疗健康事业注入新的活力，有望促进创新药械的广泛应用和推广，为患者提供更加先进、有效的治疗方案。夏科家表示，上海市医保局将密切关注政策实施效果，不断优化多元支付机制，确保政策措施能够真正惠及广大患者，推动医疗领域的创新发展。
综上所述，《上海市进一步完善多元支付机制支持创新药械发展的若干措施》的出台标志着上海医疗体系向更加开放、创新的方向迈出了坚实的一步，也为全市的医疗卫生事业发展注入了新的动力和活力。希望这一政策能够顺利实施，为上海市民的健康保驾护航，为医疗行业的进步贡献力量。
英语如下：
News Title: Shanghai Introduces Innovative Pharmaceutical Diversified Payment Protection Policy
Keywords: Shanghai innovative pharmaceuticals, diversified payment, protection mechanism
News Content: Xia Kejia, Director of the Shanghai Medical Insurance Bureau, stated on March 1st that in order to further promote the development of innovative pharmaceuticals and medical devices, Shanghai will introduce the “Several Measures to Further Improve the Diversified Payment Mechanism to Support the Development of Innovative Pharmaceutical Devices in Shanghai”. The core objective of this policy is to establish a diversified payment protection mechanism to incentivize medical institutions to more actively introduce innovative pharmaceuticals, allowing insured individuals to use these innovative products with greater peace of mind, while also encouraging innovative pharmaceutical companies to be more daring in their research and development efforts.
Xia Kejia pointed out that the introduction of the new policy aims to break the constraints of traditional medical insurance payment models and provide more flexible and diversified payment methods for innovative pharmaceuticals. By enhancing the diversified payment mechanism, Shanghai hopes to encourage medical institutions to be more adventurous in choosing to use innovative pharmaceuticals, providing better treatment options for patients; at the same time, to instill confidence in insured individuals when they need to use innovative pharmaceuticals, alleviating concerns about costs. Most importantly, it encourages innovative pharmaceutical companies to be more adventurous in the research and development process, driving continuous advancements in medical technology.
The introduction of this policy will inject new vitality into Shanghai’s healthcare industry, potentially promoting the widespread application and dissemination of innovative pharmaceuticals, providing patients with more advanced and effective treatment options. Xia Kejia stated that the Shanghai Medical Insurance Bureau will closely monitor the implementation effects of the policy, continuously optimize the diversified payment mechanism, ensuring that the policy measures truly benefit a wide range of patients and drive innovative development in the medical field.
In conclusion, the introduction of the “Several Measures to Further Improve the Diversified Payment Mechanism to Support the Development of Innovative Pharmaceutical Devices in Shanghai” signifies a solid step towards a more open and innovative direction for Shanghai’s medical system, injecting new momentum and vitality into the city’s healthcare industry. It is hoped that this policy will be smoothly implemented, safeguarding the health of Shanghai residents and contributing to the progress of the medical industry.
【来源】http://www.chinanews.com/life/2024/03-01/10172770.shtml
Views: 1